´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2020³â Ãá°è½ÉÆ÷Áö¾ö : 2020-03-19±³À°ÀÏÀÚ : 2020-03-19
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼¿ï È£ÅÚ
±³À°ÁÖÁ¦ :
2020³â Ãá°è½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
´ã´çÀÚ : ±èÈñ¼ø
¿¬¶ôó : 02-795-9914
À̸ÞÀÏ :
kscp3@kams.or.kr ±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 19 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 250,000¿ø
ºñ°í Á¤È¸¿ø 10¸¸¿ø/ ÁØȸ¿ø 8¸¸¿ø/ ºñȸ¿ø 25¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-19 °ÀǽÇ1 09:00~09:30 ·Õ¸®µå½ÃÄö½Ì ±â¼ú°ú °á°úºÐ¼® À±È«¼®(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 03-19 °ÀǽÇ1 09:30~10:00 À¯ÀüÁúȯ¿¡¼ ·Õ¸®µå½ÃÄö½Ì ±â¼úÀÇ Àû¿ë ¼º¹®¿ì(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ1 10:00~10:30 °¨¿°Áúȯ¿¡¼ ·Õ¸®µå½ÃÄö½Ì ±â¼úÀÇ Àû¿ë ¿ëµ¿Àº(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ2 09:00~09:30 Áø´Ü¸é¿ª°Ë»ç °Ë»ç½ÇÀÚü°³¹ß°Ë»çÀÇ °ËÁõ ¹× Á¤µµ°ü¸® ½Å°æÈ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ2 09:30~10:00 Ç÷Àå EGFR °Ë»çÀÇ ºÐ¼® Àü °úÁ¤ ÃÖÀûȸ¦ À§ÇÑ Áöħ ÀÌ°æ¾Æ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ2 10:00~10:30 Ç÷¾×¹è¾ç äÃë Áöħ ±¹³» ÇöȲ°ú Àü¹®°¡ Á¦¾È ÀÌÀçÇö(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ2 10:30~11:00 ±¹³»¿¡¼ »ç¿ëÇÏ´Â A1°ú H lectin½Ã¾àÀÇ ¹ÝÀÀµµ ºñ±³ Æò°¡ ÀÓÁöÇâ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ3 09:00~09:30 ½ÅÀÔ Àü°øÀÇ ¿À¸®¿£Å×ÀÌ¼Ç ±è°æÈñ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ3 09:30~10:00 ÁöÁú°Ë»çÀÇ Ç¥ÁØÈ ÀÌ»ó±¹(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ3 10:00~10:30 Ç÷¾×ÀºÇàÀÇ Á¤µµ°ü¸® ÀÌÇöÁö(¾ç»êºÎ»ê´ëÇб³º´¿ø)
±³À°½Ã°£ 03-19 °ÀǽÇ3 10:30~11:00 ÀÓ»ó Â÷¼¼´ë¿°±â¼¿°Ë»çÀÇ ±âÃÊ ±èÁöÀº(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ1 11:10~12:00 ÀÇ»ý¸í°øÇÐ ºÐ¾ß ÀÀ¿ëÀ» À§ÇÑ DNA À¯µµ ±Ý ³ª³ëÀÔÀÚ ÇÕ¼º ±â¼ú ½É»óÁØ(°í·Á´ë È°ø»ý¸í°øÇаú)
±³À°½Ã°£ 03-19 °ÀǽÇ1 13:00~13:50 Áø´Ü°Ë»çÀÇ °³¹ß°ú ÀÓ»óÆò°¡ °æÇè ±è¿ë±¸(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ1 14:10~14:40 °íÇüÁ¾¾ç¿¡¼ customized targeted NGS ÆгÎÀ» ÀÌ¿ëÇÑ ctDNA °Ë»ç À̽ÂÅÂ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ1 14:40~15:10 Clinical utility of comprehensive cell-free DNA (cfDNA) analysis to dentify genomic markers in metastatic NSCLC Natasha B Leighl(Princess Margaret Cancer Centre)
±³À°½Ã°£ 03-19 °ÀǽÇ1 15:10~15:40 ctDNA¸¦ ÀÌ¿ëÇÑ ¾×ü»ý°ËÀÇ ÀÓ»óÀû À¯¿ë¼º°ú °úÁ¦ ±è¿È«(°í·ÁÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ2 14:10~14:40 Digitized morphology today Gina Zini(Catholic University of the Sacred Heart)
±³À°½Ã°£ 03-19 °ÀǽÇ2 14:40~15:10 Red cell and reticuloytes measurements: state of the art, technology and expectations Giuseppe D(Editor, International Journal of Laboratory Hematology)
±³À°½Ã°£ 03-19 °ÀǽÇ2 15:10~15:40 MicroRNA in myelodypslastic syndrome °¼ºÈ£(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ3 14:10~14:40 ÁöµµÀü¹®ÀÇ ÀÚ°Ý ¹× ¿ªÇÒ ±Ç¹ÎÁ¤(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ3 14:40~15:10 Áø´Ü°Ë»çÀÇÇаú ÀÇ»çÀÇ ´ÙÇÐÁ¦Áø·á Âü¿© ½Å»õ¾Ï(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ3 15:10~15:40 Áø´Ü°Ë»çÀÇÇÐ Àü¹®ÀǷμÀÇ °Ë»ç½Ç ¿î¿µ Á¶¼ºÀº(·¦Áö³ë¹Í½º)
±³À°½Ã°£ 03-19 °ÀǽÇ3 15:40~16:10 °Ëü°Ë»ç ±Þ¿©¼ö°¡ÀÇ ±¸Á¶ ÀÌ»ó°ï(³ì½ÊÀÚÀÇ·áÀç´Ü)
±³À°½Ã°£ 03-19 °ÀǽÇ3 16:30~17:00 Áø´Ü°Ë»çÀÇÇÐ ±³°ú¼ ¾²±â ÀÌ¿ëÈ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ3 17:00~17:30 Áø´Ü°Ë»çÀÇÇÐ ¿ë¾î ¹Ù·Î ¾Ë±â ÇöÁ¤¿ø(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ3 17:30~18:00 Àü¹®ÀÇ ½ÃÇè¹®Ç× ÃâÁ¦ °¡À̵å¶óÀÎ È«À±Áö(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 03-19 °ÀǽÇ4 14:10~14:40 °áÇÙ Ä¡·áÈ¿°ú Æò°¡¸¦ À§ÇÑ ¹ÙÀÌ¿À¸¶Ä¿ ¿¬±¸ À̼º°æ(Áúº´°ü¸®º»ºÎ ±¹¸³º¸°Ç¿¬±¸¿ø)
±³À°½Ã°£ 03-19 °ÀǽÇ4 14:40~15:10 TCR ·¹ÆÛÅä¾î ºÐ¼®ÀÌ °áÇÙÀÇ Áø´Ü ¹× Ä¡·á¿Í ¸¸³¯ ¶§ Á¶À±Á¤(°í·ÁÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ4 15:10~15:40 ´ë»çüºÐ¼® ±â¹ýÀ» ÀÌ¿ëÇÑ °áÇÙ ¿¬±¸ µ¿Çâ Ȳ¿µÀÚ(°í·Á´ë ¾àÇдë)
±³À°½Ã°£ 03-19 °ÀǽÇ1 16:10~16:35 Implantable glucose biosensors for clinical use ÇãÀ±Á¤(°æÈñ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ1 16:35~17:00 ÀÚ¿¬¸ð»ç Ç¥¸é ±â¹Ý ÷´Ü ¹ÙÀÌ¿À¼¾¼ ¹× ÀÇ·á±â±â ¼Á¤¸ñ(¿¬¼¼´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ1 17:00~17:25 ³ª³ëÀÔÀÚ¸¦ ÀÌ¿ëÇÑ ÇÙ»êÀÇ ½Å¼Ó °ËÃâ Ȳ»óÇö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ1 17:25~17:50 ÀÓ»ó¿¡ È°¿ëµÇ´Â ÀÚ¿¬»ìÇؼ¼Æ÷ ±â´É °Ë»ç Á¶´ö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ2 16:10~16:30 Áú°ü¸®Ã¼°è ±è¼ÖÀÙ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ2 16:30~16:50 °úÁ¤°ü¸® ¼µ¿Èñ(·¦Áö³ë¹Í½º)
±³À°½Ã°£ 03-19 °ÀǽÇ2 16:50~17:10 »ç°Ç°ü¸® ÀÌ¿µ°æ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ2 17:10~17:40 Á¤º¸°ü¸® À±¿µ¾È(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ4 16:10~16:40 ÀÓ»ó¹Ì»ý¹° ºÐ¾ßÀÇ »õ·Î¿î µµÀü: ÆÐÇ÷ÁõÀÇ ½Å¼Ó Áø´Ü ¹Ú°æ¿î(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ4 16:40~17:10 Rapid AST (antimicrobial susceptibility testing): options and successes ÀÌÇõ¹Î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03-19 °ÀǽÇ4 17:10~17:40 ÀÓ»ó¹Ì»ý¹° °Ë»çÀÇ º¯È: ÀÌÀü°ú ´Ù¸¥ »õ·Î¿î Á¢±Ù ±èÀç¼®(ÇѸ²ÀÇ´ë)